Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis

Trial Profile

Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Denosumab (Primary) ; Teriparatide (Primary)
  • Indications Osteoarthritis; Osteoporosis
  • Focus Biomarker; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 20 Dec 2017 Planned End Date changed from 31 Dec 2019 to 31 Dec 2021.
    • 20 Dec 2017 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2020.
    • 29 Oct 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top